Form 8-K RECURSION PHARMACEUTICAL For: Jun 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
Recursion Pharmaceuticals (RXRX) to cut 20% staff
June 10, 2025 6:21 AM EDTOn June 10, 2025, Recursion Pharmaceuticals (NASDAQ: RXRX), announced a reduction in personnel and infrastructure aligned with the Companys previously announced streamlined operating strategy and post-integration employee transitions. Based on its revised expense profile and business plan, the Company now expects its projected cash runway to extend into... More



